| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $58.8M | — | +10.3% |
| Cost of Revenue | $4.6M | — | +4.5% |
| R&D Expense | $11.7M | — | +38.4% |
| SG&A Expense | $30.7M | — | +10.6% |
| Operating Income | $11.9M | — | -7.0% |
| Interest Expense | $1.4M | — | -24.4% |
| Pre-tax Income | $11.7M | — | +1.3% |
| Income Tax | $3.0M | — | +4520.0% |
| Net Income | $8.7M | — | -24.4% |
| EPS (Basic) | $0.47 | — | -26.6% |
| EPS (Diluted) | $0.44 | — | -30.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $24.4M | -39.8% | -46.6% |
| Short-term Investments | $122.3M | +6.9% | +289.8% |
| Accounts Receivable | $49.9M | -3.5% | +20.2% |
| Inventory | $11.7M | +1.3% | +150.1% |
| Current Assets | $234.0M | -2.6% | +59.7% |
| Total Assets | $504.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.7M | — | +405.2% |
| Investing Cash Flow | -$8.0M | — | +24.4% |
| Financing Cash Flow | -$10.9M | — | -2356.0% |
| +186.8% |
| Current Liabilities | $89.5M | -9.8% | +34.3% |
| Long-term Debt | $45.0M | -14.3% | -25.0% |
| Total Liabilities | $104.7M | -14.3% | -33.5% |
| Stockholders' Equity | $399.9M | +2.2% | +2053.8% |